We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SAR.LSE

Price
17.50
Stock movement up
+- (%)
Company name
Sareum Hldgs Plc
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Biotechnology
Market cap
2.18B
Ent value
2.18B
Price/Sales
-
Price/Book
1032.67
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
10.43%
1 year return
6.06%
3 year return
-59.19%
5 year return
-12.57%
10 year return
0.74%
Last updated: 2025-04-12

DIVIDENDS

SAR.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales-
Price to Book1032.67
EV to Sales-

FINANCIALS

Per share

Per share data
Current share count124.75M
EPS (TTM)-0.06
FCF per share (TTM)-0.10

Income statement

Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-1.00K
Operating income (TTM)-6.90M
Net income (TTM)-5.17M
EPS (TTM)-0.06
EPS (1y forward)-3.60

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.46M
Net receivables1.30M
Total current assets2.76M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.77M
Accounts payable542.00K
Short/Current long term debt0.00
Total current liabilities653.00K
Total liabilities653.00K
Shareholder's equity2.11M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-6.76M
Capital expenditures (TTM)1.22M
Free cash flow (TTM)-7.98M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-244.37%
Return on Assets-186.70%
Return on Invested Capital-244.37%
Cash Return on Invested Capital-377.34%

STOCK INFORMATION

Stock chart

Stock price data
Open17.50
Daily high18.25
Daily low16.84
Daily Volume116K
All-time high457.50
1y analyst estimate176.00
Beta-0.98
EPS (TTM)-0.06
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
SAR.LSES&P500
Current price drop from All-time high-96.17%-12.89%
Highest price drop-98.58%-56.47%
Date of highest drop5 Feb 20099 Mar 2009
Avg drop from high-75.06%-11.07%
Avg time to new high166 days12 days
Max time to new high3982 days1805 days
COMPANY DETAILS
SAR.LSE (Sareum Hldgs Plc) company logo
Marketcap
2.18B
Marketcap category
Mid-cap
Description
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also involves in developing SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Checkpoint kinase 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
Employees
5
Website
https://www.sareum.com
Investor relations
-
SEC filings
SAR.LSE SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved